October 8, 2013 11:19 AM | 1 min read |
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
IMRIS (NASDAQ: IMRS) and Stryker Corporation (NYSE: SYK) today announced a non-exclusive collaboration between Stryker's automatic image registration for spinal and cranial navigated procedures and VISIUS® iCT and VISIUS iMRI surgical suites from IMRIS."Having these tools work together is an exciting opportunity for surgeons utilizing intraoperative CT and MRI in our VISIUS® Surgical Theatres. This open platform collaboration aligns squarely with our goal of providing state-of-the-art imaging at the point of therapy," said Jay D. Miller, IMRIS President and CEO.IMRIS markets the VISIUS Surgical Theatre with intraoperative CT and MRI options to provide surgical teams with on-demand access to state-of-the-art, diagnostic quality imaging. The IMRIS solution makes these valuable images possible at key points in the surgery with patented technology that brings the scanner into the OR rather than requiring the surgeon to bring the patient to the scanner."We are excited to partner with IMRIS to bring streamlined surgical solutions into integrated CT and MRI capable operating rooms. IMRIS shares our open platform philosophy and we believe that through this partnership we will improve the
See full press release
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.